At the PAAB General Meeting of April 29, 2000, the PAAB members agreed to revise PAAB Code of Advertising Acceptance section 7.8 and Explanatory Note section 7.8.1. This revision will help clarify to advertisers that pre-Notice of Compliance advertising is not acceptable within the PAAB Code. Messages paid by pharmaceutical companies to provide information about therapeutic classes of drugs or treatment of disease require PAAB preclearance review. Some messages may not be deemed to be “advertising” by the Health Canada definition but are deemed to be advertising by the PAAB Code definition. This includes “teaser ads” that may not comply with the PAAB Code. Therefore, it necessitates the need for PAAB review of this type of advertising.
Never miss an update. Get the latest PAAB info delivered right to your email address.
In an effort to constantly serve our clients better, PAAB has unveiled a new electronic submission process(eFiles). Effective January 2, 2008 all submissions will have to be submitted via the eFiles system. Please have a Senior Official (Director level) send an email to the administration team at review@paab.ca with the contact information of the person(s) who will be designated as administrator(s) for your company. Click on eFiles, on the menu, then eFiles Tutorial for a tutorial on how eFiles works.
Please contact the admin team at PAAB if you need assistance with eFiles
The Accelerated Preclearance Pathway
Learn more and share your feedback by April 14
Click here to provide feedback